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Findings are described in six patients with no clinical 
evidence of heart disease who had documented ventricular 
fibrillation (five patients) or ventricular flutter (one pa- 
tient). The mean age of the six patients, all men, was 34 
years (range 26 to 43). Cardiovascular collapse occurred in 
all and was followed by successful cardioversion. No patient 
had electrolyte or QT abnormalities. One patient had slight 
right ventricular enlargement on M-mode echocardiog 
raphy, and another had a left ventricular pressure gradient 
at rest of 30 mm Hg with a normal two-dimensional 
echocardiogram. Holter electrocardiographic monitoring 
revealed incessant ventricular tachycardia in one patient 
and nonsustained ventricular tachycardia in three others. 
Exercise testing revealed nonsustained ventricular tachy- 
cardia in one patient. 
Sudden cardiac death is usually secondary to ventricular 
fibrillation or rapid ventricular tachycardia in patients with 
coronary artery disease (I). Nonischemic sudden cardiac 
death is usually associated with aortic valve disease, cardio- 
myopathy or the long QT syndrome (l-3). In patients 
without overt heart disease, ventricular tachycardia has 
been widely reported (4-9). However, the occurrence of 
ventricular fibrillation in patients without clinical evidence of 
heart disease is unusual (S-18). The purpose of this study is 
to present the clinical course, electrophysiologic features 
and long-term follow-up of six such patients seen at our 
institution during the last 6 years. 
Methods 
Study patients. All six patients were referred to our 
institution for evaluation and treatment of at least one 
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Ventricular fibrillation was induced at the time of 
programmed electrical stimulation in four of the six pa- 
tients. Documented recurrence of ventricular fibrillation or 
ventricular flutter occurred in three patients, but in only 
one patient receiving antiarrhythmic drugs. Four patients 
were treated with amiodarone and one received an auto- 
matic implantable cardioverter-defibrillator. All patients 
are alive after a mean follow-up period of 78 months after 
the first documentation of their arrhythmia and 37 months 
after programmed electrical stimulation. 
Ventricular fibrillation can occur in the apparently 
structurally normal human heart. Antiarrhythmic treat- 
ment can provide effective control of this malignant 
arrhythmia. 
(J Am Co11 Cardiol1989;13:911-6) 
documented episode of ventricular fibrillation (five patients) 
or ventricular flutter (one patient) requiring emergency car- 
diopulmonary resuscitation. Patients underwent a history 
and physical examination, chest radiography, I2 lead elec- 
trocardiogram (ECG) and M-mode and two-dimensional 
echocardiography. All patients had cardiac catheterization, 
right and left ventricular angiography and coronary arteriog- 
raphy . Patients 2 and 4 were also given ergonovine maleate 
during arteriography, although coronary spasm for the cause 
of the arrhythmia was not suspected clinically in any of the 
six patients. Continuous ECG monitoring was performed 
during hospitalization, and patients exercised on a treadmill 
or bicycle ergometer. 
Electrophysiologic study. Programmed electrical stimula- 
tion was performed in all patients with use of two to three 
quadripolar electrode catheters introduced percutaneously 
from the femoral vein. Four patients had a baseline study 
after discontinuation of all antiarrhythmic drugs for at least 
five half-lives. the other two patients were studied while they 
were receiving antiarrhythmic drug treatment (Table I). In 
one patient. programmed electrical stimulation was repeated 
during treatment with oral amiodarone. Programmed electri- 
cal stimulation was performed in patients in the postabsorp- 
tive nonsedated state after informed consent was obtained. 
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Table 1. Electrophysiologic Features and Course of Events in Six Patients 
Pt History of CV Collapse 
Treatment* 
At Collapse Started 
Lown Class EPS F-Up (mo) 
VERP 
Ventricular Init 6001500 1st 
AM ExT Arrhythmia tmsl Term (ms) Ret Dot EPS 
I 1. I2 yr pre-EPS IO mitt collapse None 
2. 9 yr pre-EPS collapse; V fl, Rx CV None 
3. I mo pre-EPS collapse x 3; V fl, Rx 
cv 
None 
2 I. Collapse at home; adm in AF 
V rate 70 to 120 beatsimin; NSVT; 
VTIVF, Rx CV 
None 
3 I. Visit to clinic for palpitation 
NSVT dot; Adm VTIVF, Rx CV 
None 
4 I. Collapse while shoveling; CPR started; 
dot VF. CV x 3 
None 
5 1. IO yr pre-EPS collapse at home, CV 
Xl 
None 
2. 
3. 
8 yr and 3 yr Pf-EPS pre-syncope 
I mo pre-EPS, collapse while taking 
a bath, CRP; dot VF, Rx CV, lido IV, 
bretylium IV; VF next day, Rx CV 
None 
6 1. 20 mo pre-EPS; collapse: adm 
VF x 2, Rx CV 
None 
2. 
3. 
Collapse at home; adm 
In CCU awaiting AICD; recurrent 
VTIVF, CV x 2 
Dil loO+ 
Met 50 
Dil 200+ 
Met 100 
None - - 
- - 
Qxlyr 0 0 
0 0 
Yes 
Yes 
2301220 
Q 0 0 
0 0 
Amio 2OOiday 0 0 
- 
- 
- 
V fl (6 beats) SR, Spont 
VF SR,,, CV 
NSPVT 6002,s Spont 
VF 600, CV 
NSPVT 600 i.?.s Spent 
No I68 60 
- 
- 
IV lido Inc 
IV diso VT 
IV procain 
IV sotalol 
Amio 200iday 2 2 
lncess VT 
(RBBB. RAD) 
No 56 56 
- 
- 
4b 0 VF 
Amio 200iday - 0 - 
SR, cv 
Before EPS 4b - 
aprin, alpren 4b 
mex, amio 
- 
No 50 50 
2101190 
No 30 30 
Yes 
Amio 8OOt 4b 4a 
Aprin 100 
Amio 400 t 
Aprin 75 - 4b 
Nl Sk 2701230 
- 
4b - 
Dil 200t - II 
Met 100 
4b 0 
- 
No 136 I4 
Yes 
NSPVT ‘30% 
VF 600, 
2101190 
4b - Yes 
AICD 
Dil 200 - 
- 
Prop 320 
- 
No 30 9 
*All drug dosages are in milligrams per day. adm = admission; AF = atrial fibrillation; AICD = automatic implantable cardioverter-defibrillator; alpren = 
alprenolol; AM = ambulatory monitoring: amio = amiodarone: aprin = aprindine; CCU = coronary care unit; CPR = cardiopulmonary resuscitation; CV = 
cardioversion; dil = Dilantin: diso = disopyramide: dot = documented: ESP = electrophysiologic study: ExT = exercise testing; 1st dot = first documentation 
of the ventricular arrhythmia; F-Up = duration of follow-up; lnit = initiation: Inc VT = incessant ventricular tachycardia; IV = intravenous; lido = lidocaine; 
Lown = Lown arrhythmia class; met = metoprolol; mex = mexiletine; NS = nonsustained; NSPVT = nonsustained polymorphic ventricular tachycardia; procain 
= procainamide; prop = propranolol; Pt = patient: Q = quinidine; RAD = right axis deviation: RBBB = right bundle branch block; Ret = recurrence of 
ventricular flutter or ventricular fibrillation; Rx = treatment; Spont = spontaneous: SR = sinus rhythm; Term = termination: V = ventricular: VERP = 
ventricular effective refractory period: VF = ventricular fibrillation: V fl = ventricular flutter: VT = ventricular tachycardia; l-2-3-4 = number of ventricular beats 
given during programmed electrical stimulation (the presence of more than one number refers to reproducible induction of the ventricular arrhythmia); 6001500 
= ventricular pacing at 600 or 500 ms. 
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Intracavitary electrograms and ECG leads I, II, III. V,. 
V, and V, were recorded on a multichannel recorder at a 
paper speed of 100 mm/s. Programmed electrical stimulation 
was performed according to our previously described proto- 
col (19) with delivery of rectangular stimuli of I to 2 ms 
duration at twice diastolic threshold. Ventricular stimulation 
was performed from the right ventricular apex in all patients. 
Single, double and triple ventricular extrastimuli were given 
in three patients: in two patients, a fourth ventricular ex- 
trastimulus was also given. 
Follow-up. Long-term follow-up was obtained in all pa- 
tients by visit to the outpatient clinic. We assessed the length 
of follow-up from the initial documentation of ventricular 
fibrillation or ventricular flutter and from the time of pro- 
grammed electrical stimulation. 
Results 
Clinical and laboratory features. All patients were men: 
their mean age was 34 years (range 26 to 43). A history of 
palpitation was present in two patients. Patient 4 was the 
only patient who collapsed during exercise (while shoveling 
dirt). This patient also had an uncle who died suddenly at the 
age of 28 years. No patient had a history of chest pain. 
shortness of breath or alcohol or drug abuse. A history of 
smoking was present in three patients. Patient 2 worked with 
insecticides, but no known toxic exposure had occurred. 
Physical exclminrttion was normal in three patients. and 
two others had a grade 216 systolic ejection murmur. Patient 
4 had a systolic click and a grade 216 systolic ejection 
murmur, but had no mitral valve prolapse during M-mode 
and two-dimensional echocardiography (performed at rest. 
during Valsalva maneuver and while inhaling amyl nitrate) or 
during left ventricular angiography. 
Chest radiographs li’ere normtd in ull prrtients. The ECG 
showed complete and incomplete right bundle branch block 
in Patient 1 and Patient 6, respectively. The other four 
patients had a normal 12 lead ECG. The QTc interval was 
CO.45 s in all patients. 
M-mode und tlclo-dinzensioncrl echourrdiogrrlphic results 
were normal in all but Patient 6, who had two echocardio- 
graphic studies that revealed a slightly increased end- 
diastolic right ventricular dimension of 34 mm (normal <30 
mm). This patient had normal right and left ventriculograms, 
and no gross cardiac abnormalities noted at the time of 
implantation of an automatic cardioverter-defibrillator. 
Cmrdiu cuthetcrization revealed a slightly elevated right 
ventricular end-diastolic pressure of 10 mm Hg in Patient 5. 
and normal right ventricular pressure in all other patients. 
The left ventricular end-diastolic pressure at rest was slightly 
elevated (IS mm Hg) in Patient 2. Patient 3 had a left 
ventricular end-diastolic pressure of 28 mm Hg, but inces- 
sant ventricular tachycardia was present at the time of the 
study. Patient 4 had a left ventricular pressure gradient at 
rest of 30 mm Hg, which increased to 35 mm Hg with 
isoproterenol (this patient had the systolic click and murmur 
described earlier). The remaining three patients had a normal 
left ventricular pressure. All patients had a left ventricular 
ejection fraction ~60%. Angiographic features were normal 
in all but Patient 4, who exhibited hypertrophy of the 
papillary muscles. 
Electrophysiologic features (Table 1). In all patients with 
documented ventricular fibrillation and in the patient with 
ventricular flutter the arrhythmia occurred in the absence of 
antiarrhythmic drug therapy. In three patients, it occurred 
shortly after admission to the hospital: the other three 
patients were resuscitated from an out-of-hospital cardiac 
arrest. Patient 3 had incessant ventricular tachycardia at the 
time of admission. and responded promptly to oral amioda- 
rone given over the first few days of admission. Non- 
sustained ventricular tachycardia was present during contin- 
uous monitoring in three patients, and Patient 6 also had 
isolated R on T ectopic ventricular extrasystoles (coupling 
interval ~300 ms). Exercise testing revealed nonsustained 
ventricular tachycardia in one patient. 
Inducible ventricular fibrillation. During programmed 
electrical stimulation, ventricular fibrillation was induced in 
two patients with use of three premature ventricular stimuli, 
in one patient with both three and four ventricular extrastim- 
uli and in another patient with four ventricular extrastimuli. 
Patient 3 had incessant ventricular tachycardia at the time of 
programmed electrical stimulation, and overdrive pacing 
only partially suppressed the ventricular tachycardia: endo- 
cardial mapping showed earliest endocardial activation dur- 
ing ventricular tachycardia at the anterior portion of the left 
side of the ventricular septum. In this patient, the ventricular 
effective refractory period could not be obtained, but in four 
other patients, it was obtained during right ventricular pac- 
ing at 100 and I20 beatsimin and ranged from 190 to 270 ms. 
Inducible ventricular tachycardia. None of the patients 
had sustained monomorphic ventricular tachycardia induced 
during programmed electrical stimulation. Nonsustained 
polymorphic ventricular tachycardia was induced in two 
patients, and nonsustained ventricular flutter was induced in 
the patient who presented with sustained ventricular flutter. 
Antiarrhythmic drug studies. Three patients underwent 
programmed electrical stimulation while receiving anti- 
arrhythmic drugs. Two patients had a favorable study: with 
use of up to three premature ventricular stimuli, Patient 4 
(amiodarone. 800 mgiday and aprinidine, 100 mg/day) had no 
inducible tachycardia. whereas Patient 2 (amiodarone, 200 
mgiday) had inducible nonsustained polymorphic ventricular 
tachycardia. In Patient 6. who collapsed while taking Dilantin 
( 100 mg/day) and metoprolol (50 mgiday), ventricular fibrilla- 
tion was induced with three premature ventricular stimuli. 
Follow-up. Documented ventricular flutter recurred in Pa- 
tient I after discontinuation of quinidine therapy. Patient 5 
had recurrence of ventricular fibrillation after recent discon- 
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tinuation of antiarrhythmic drug therapy (drug levels at the 
time of admission for ventricular fibrillation were aprindine, 
0.08 pg/ml, and amiodarone, 0.63 &ml). The course of 
events in Patient 6 is depicted in Figure 1, which shows 
recurrent episodes of polymorphic ventricular tachycardia or 
ventricular fibrillation during continuous ECG monitoring. 
Long-term follow-up after the jirst documented episode 
of ventricularfibrillation or ventricularfiutter ranged from 30 
to 168 months (mean 78) and after programmed electrical 
stimulation from 12 to 60 months (mean 37). The patient with 
ventricular flutter was treated with quinidine. Three patients 
with ventricular fibrillation have been treated with amioda- 
rone alone, and another is receiving amiodarone and a 
beta-adrenergic blocking agent. Patient 6 has been treated 
with dilantin, propranolol and an automatic implantable 
cardioverter-defibrillator; At last follow-up, 18 months after 
implantation of the device, no shocks had been delivered. 
Discussion 
This report describes six men without overt heart disease, 
who were successfully resuscitated from sudden cardiac 
death. Ventricular fibrillation was documented in five pa- 
Figure 1. Course of events in Patient 6 as shown on the 
tracings obtained during continuous monitoring at the 
time of both admissions (adm). The patient had numer- 
ous episodes of R on T ventricular premature beats 
(VPB), with a short coupling interval (<300 ms), non- 
sustained polymorphic ventricular tachycardia 
(NSPVT) (and possibly torsade de pointes) and a total of 
three in-hospital documented episodes of ventricular 
fibrillation (VF), all successfully converted to sinus 
rhythm by defibrillation. HR = heart rate; PES = 
programmed electrical stimulation; SR = sinus rhythm. 
tients and ventricular flutter occurred in the other. A distinc- 
tive causative metabolic, electrical or anatomopathologic 
abnormality could not be found in any of these patients. 
Although there have been several reports (4-9) of ventricular 
tachycardia occurring in patients without structural heart 
disease, there have been only isolated case reports of 
documented ventricular fibrillation or flutter (8-18) in such 
patients. 
Cause of sudden death. Twenty percent of all cases of 
sudden cardiac death occur in the absence of coronary artery 
disease (1). Although numerous causes may be found, the 
majority of cases are secondary to hypertrophic cardiomy- 
opathy, aortic valve disease and the long QT syndrome, 
either hereditary or caused by metabolic disturbances or 
antiarrhythmic drugs (l-3,20-22). Instances of cardiac arrest 
have also been reported in association with mitral valve 
prolapse (23,24), the Wolff-Parkinson-White syndrome (25), 
arrhythmogenic right ventricular dysplasia (26), coronary 
artery spasm (27-29) and drug exposure. Ail of our patients 
had subtle abnormalities during noninvasive or invasive 
studies, but none of the findings offer a precise explanation 
of the cause of sudden cardiac death. An underlying myo- 
carditis cannot be excluded in our patients. Reports of 
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abnormal cardiac histologic findings in patients with malig- 
nant ventricular arrhythmias of unknown origin have been 
described (9,30,31). In one report (9). the only patient with 
ventricular fibrillation was also the only one to have normal 
cardiac histologic findings. 
Mechanism of ventricular fibrillation. Sustained mono- 
morphic ventricular tachycardia was not seen clinically and 
could not be induced in any of the patients; this finding 
suggests that the mechanism of ventricular fibrillation is not 
reentry (32). Several factors suggest that. in this group of 
patients, ventricular fibrillation is a primary event: I) the 
absence of a sustained ventricular tachycardia before ven- 
tricular fibrillation, in contrast to the usual association (33); 
2) the clinical observation of only short runs of ventricular 
tachycardia preceding ventricular fibrillation (Patients 3 and 
6); and 3) the inducibility of ventricular fibrillation with three 
or four extrastimuli during programmed electrical stimula- 
tion in four of the six patients (34). Josephson et al. (35) 
suggested that these factors may produce inhomogeneity in 
ventricular activation and recovery, as well as shorten 
ventricular refractoriness, and thus provide the unstable 
substrate needed for the development of ventricular fibrilla- 
tion. 
Ventricular fibrillation recurred during antiarrhythmic 
therapy in only Patient 6 (who was receiving dilantin and a 
beta-blocking agent): all other patients with ventricular 
fibrillation were treated with amiodarone. The absence of 
recurrence of ventricular flutter or ventricular fibrillation in 
five of the six medically treated patients and the increasing 
availability of the automatic implantable cardioverter-de- 
fibrillator (40) should improve the prognosis of this unique 
group of patients who have been successfully resuscitated 
from sudden cardiac death. 
We thank Adri van den Dool. RN for assistance in the preparation of this 
manuscript. 
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